Annals of internal medicine
-
Comment Randomized Controlled Trial
In cancer with dyspnea, high-dose dexamethasone did not improve dyspnea and increased SAEs.
Hui D, Puac V, Shelal Z, et al. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial. Lancet Oncol. 2022;23:1321-31. 36087590.
-
The durability of the antibody response after SARS-CoV-2 infection and the role of antibodies in protection against reinfection are unclear. ⋯ Agency for Healthcare Research and Quality. (PROSPERO: CRD42020207098).
-
Comment Randomized Controlled Trial
In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d.
Hsia J, Guthrie NL, Lupinacci P, et al. Randomized, controlled trial of a digital behavioral therapeutic application to improve glycemic control in adults with type 2 diabetes. Diabetes Care. 2022;45:2976-81. 36181554.
-
Meta Analysis
Anticoagulant Therapy for Cancer-Associated Thrombosis : A Cost-Effectiveness Analysis.
Direct oral anticoagulants (DOACs) offer an alternative to low-molecular-weight heparin (LMWH) and warfarin for treating cancer-associated thrombosis (CAT). ⋯ None.
-
Randomized Controlled Trial
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.
Acute hospitalizations are common in patients with chronic kidney disease (CKD) and often lead to decreases in health-related quality of life and increased care costs. ⋯ AstraZeneca.